Hirono I, Haga M, Fujii M, Matsuura S, Matsubara N, Nakayama M, Furuya T, Hikichi M, Takanashi H, Uchida E, Hosaka S, Ueno I
J Natl Cancer Inst. 1979 Aug;63(2):469-72.
The carcinogenicity of the pyrrolizidine alkaloids senkirkine and symphytine was studied in male inbred ACI rats. Animals were divided into 3 groups: Group I received ip injections of freshly prepared senkirkine at a dose of 10% of the median lethal dose (LD50) twice weekly for 4 weeks and then once a week for 52 weeks. Group II received ip injections of symphytine at a dose of 10% of the LD50 by the same injection schedule as in group I. The control group was given ip injections of a 0.9% NaCl solution following the same injection schedule as in experimental groups. All group I rats survived for more than 290 days after the start of injections, and 9 of 20 rats developed liver cell adenoma. All group II animals survived for more than 330 days after the start of injections. Of 20 rats, 4 had liver tumors, 3 had hemangioendothelial sarcomas, and 1 had liver cell adenoma. The hemangioendothelial sarcomas showed metastasis in the lungs of 2 rats. The control group had no liver tumors.
在雄性近交系ACI大鼠中研究了吡咯里西啶生物碱千里光碱和聚合草碱的致癌性。动物被分为3组:第I组大鼠每周两次腹腔注射新鲜配制的千里光碱,剂量为半数致死量(LD50)的10%,持续4周,然后每周一次,持续52周。第II组大鼠按照与第I组相同的注射方案腹腔注射聚合草碱,剂量为LD50的10%。对照组按照与实验组相同的注射方案腹腔注射0.9%的氯化钠溶液。所有第I组大鼠在注射开始后存活超过290天,20只大鼠中有9只发生了肝细胞腺瘤。所有第II组动物在注射开始后存活超过330天。20只大鼠中,4只患有肝肿瘤,3只患有血管内皮肉瘤,1只患有肝细胞腺瘤。2只大鼠的血管内皮肉瘤出现了肺转移。对照组未出现肝肿瘤。